These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20065134)

  • 21. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
    Caselli RJ; Dueck AC; Osborne D; Sabbagh MN; Connor DJ; Ahern GL; Baxter LC; Rapcsak SZ; Shi J; Woodruff BK; Locke DE; Snyder CH; Alexander GE; Rademakers R; Reiman EM
    N Engl J Med; 2009 Jul; 361(3):255-63. PubMed ID: 19605830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment and the role of the ApoE epsilon4-allele after stroke--a 13 months follow-up study.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Int J Geriatr Psychiatry; 2010 Aug; 25(8):833-42. PubMed ID: 19960482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
    Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
    Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL
    Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of apolipoprotein gene on cognitive impairment and recovery after traumatic brain injury.
    Ponsford J; Rudzki D; Bailey K; Ng KT
    Neurology; 2007 Feb; 68(8):619-20. PubMed ID: 17310037
    [No Abstract]   [Full Text] [Related]  

  • 27. Stroke and memory performance in elderly persons without dementia.
    Reitz C; Luchsinger JA; Tang MX; Manly J; Mayeux R
    Arch Neurol; 2006 Apr; 63(4):571-6. PubMed ID: 16606771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood socioeconomic status and genetic risk for poorer cognition in later life.
    Moorman SM; Carr K; Greenfield EA
    Soc Sci Med; 2018 Sep; 212():219-226. PubMed ID: 30048844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total cholesterol and oxysterols: early markers for cognitive decline in elderly?
    van den Kommer TN; Dik MG; Comijs HC; Fassbender K; Lütjohann D; Jonker C
    Neurobiol Aging; 2009 Apr; 30(4):534-45. PubMed ID: 17888546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
    Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
    Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive resilience among APOE ε4 carriers in the oldest old.
    Hayden KM; Gaussoin SA; Hunter JC; Manson JE; Sachs BC; Shadyab AH; Tindle HA; Mossavar-Rahmani Y; Mozhui K; Snively BM; Rapp SR; Resnick SM
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1833-1844. PubMed ID: 31418472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.
    O'Hara R; Schröder CM; Kraemer HC; Kryla N; Cao C; Miller E; Schatzberg AF; Yesavage JA; Murphy GM
    Neurology; 2005 Aug; 65(4):642-4. PubMed ID: 16116137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of smoking and time on cognitive function in the elderly without dementia.
    Reitz C; Luchsinger J; Tang MX; Mayeux R
    Neurology; 2005 Sep; 65(6):870-5. PubMed ID: 16186526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
    Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
    Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults.
    Lee BK; Glass TA; Wand GS; McAtee MJ; Bandeen-Roche K; Bolla KI; Schwartz BS
    Am J Psychiatry; 2008 Nov; 165(11):1456-64. PubMed ID: 18593777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
    Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR
    Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney function is associated with the rate of cognitive decline in the elderly.
    Buchman AS; Tanne D; Boyle PA; Shah RC; Leurgans SE; Bennett DA
    Neurology; 2009 Sep; 73(12):920-7. PubMed ID: 19657107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.